Voya Investment Management LLC Viridian Therapeutics, Inc.\De Transaction History

Voya Investment Management LLC

  • $71.9 Billion
  • Q1 2025

A detailed history of Voya Investment Management LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Voya Investment Management LLC holds 19,770 shares of VRDN stock, worth $289,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,770
Previous 19,770 -0.0%
Holding current value
$289,235
Previous $266,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$13.48 - $20.91 $21,931 - $34,020
-1,627 Reduced 7.6%
19,770 $266,000
Q4 2024

Feb 14, 2025
BUY
$17.85 - $25.71 $18,528 - $26,686
1,038 Added 5.1%
21,397 $410,000
Q3 2024

Feb 07, 2025
SELL
$12.16 - $23.33 $7,186 - $13,788
-591 Reduced 2.82%
20,359 $463,000
Q3 2024

Nov 14, 2024
SELL
$12.16 - $23.33 $7,186 - $13,788
-591 Reduced 2.82%
20,359 $463,000
Q2 2024

Feb 07, 2025
BUY
$11.6 - $17.26 $69,194 - $102,955
5,965 Added 39.81%
20,950 $272,000
Q2 2024

Dec 03, 2024
BUY
$11.6 - $17.26 $6,855 - $10,200
591 Added 2.9%
20,950 $272,000
Q2 2024

Aug 14, 2024
BUY
$11.6 - $17.26 $69,194 - $102,955
5,965 Added 39.81%
20,950 $272,000
Q1 2024

Feb 07, 2025
SELL
$17.09 - $23.82 $91,841 - $128,008
-5,374 Reduced 26.4%
14,985 $262,000
Q1 2024

Dec 06, 2024
SELL
$17.09 - $23.82 $91,841 - $128,008
-5,374 Reduced 26.4%
14,985 $262,000
Q1 2024

May 15, 2024
SELL
$17.09 - $23.82 $29,001 - $40,422
-1,697 Reduced 10.17%
14,985 $262,000
Q4 2023

Feb 07, 2025
SELL
$11.12 - $22.5 $4,114 - $8,325
-370 Reduced 2.17%
16,682 $363,000
Q4 2023

Feb 14, 2024
SELL
$11.12 - $22.5 $4,114 - $8,325
-370 Reduced 2.17%
16,682 $363,000
Q3 2023

Feb 07, 2025
BUY
$15.16 - $24.7 $4,502 - $7,335
297 Added 1.77%
17,052 $261,000
Q3 2023

Nov 14, 2023
BUY
$15.16 - $24.7 $4,502 - $7,335
297 Added 1.77%
17,052 $261,000
Q2 2023

Feb 07, 2025
BUY
$22.57 - $29.67 $55,477 - $72,928
2,458 Added 17.19%
16,755 $398,000
Q2 2023

Aug 14, 2023
BUY
$22.57 - $29.67 $55,477 - $72,928
2,458 Added 17.19%
16,755 $398,000
Q1 2023

Feb 07, 2025
SELL
$25.04 - $37.6 $151,792 - $227,931
-6,062 Reduced 29.78%
14,297 $363,000
Q4 2022

Feb 07, 2025
BUY
$18.78 - $29.74 $72,810 - $115,301
3,877 Added 37.21%
14,297 $417,000
Q4 2022

Feb 14, 2023
BUY
$18.78 - $29.74 $72,810 - $115,301
3,877 Added 37.21%
14,297 $417,000
Q3 2022

Feb 07, 2025
SELL
$10.7 - $25.5 $106,347 - $253,444
-9,939 Reduced 48.82%
10,420 $213,000
Q3 2022

Mar 03, 2023
SELL
$10.7 - $25.5 $41,483 - $98,863
-3,877 Reduced 27.12%
10,420 $213,000
Q3 2022

Nov 14, 2022
BUY
$10.7 - $25.5 $111,493 - $265,710
10,420 New
10,420 $214,000

Others Institutions Holding VRDN

# of Institutions
189
Shares Held
79.6M
Call Options Held
92.2K
Put Options Held
55.2K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $584M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email